| Product Code: ETC11530904 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Denmark Companion Diagnostics for Oncology Market Overview |
3.1 Denmark Country Macro Economic Indicators |
3.2 Denmark Companion Diagnostics for Oncology Market Revenues & Volume, 2021 & 2031F |
3.3 Denmark Companion Diagnostics for Oncology Market - Industry Life Cycle |
3.4 Denmark Companion Diagnostics for Oncology Market - Porter's Five Forces |
3.5 Denmark Companion Diagnostics for Oncology Market Revenues & Volume Share, By Diagnostic Type, 2021 & 2031F |
3.6 Denmark Companion Diagnostics for Oncology Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.7 Denmark Companion Diagnostics for Oncology Market Revenues & Volume Share, By Sample Type, 2021 & 2031F |
3.8 Denmark Companion Diagnostics for Oncology Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Denmark Companion Diagnostics for Oncology Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Denmark Companion Diagnostics for Oncology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer cases in Denmark |
4.2.2 Growing demand for personalized medicine in oncology |
4.2.3 Technological advancements in companion diagnostics for oncology |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for companion diagnostics |
4.3.2 High cost associated with developing and implementing companion diagnostics |
4.3.3 Limited reimbursement policies for companion diagnostics in Denmark |
5 Denmark Companion Diagnostics for Oncology Market Trends |
6 Denmark Companion Diagnostics for Oncology Market, By Types |
6.1 Denmark Companion Diagnostics for Oncology Market, By Diagnostic Type |
6.1.1 Overview and Analysis |
6.1.2 Denmark Companion Diagnostics for Oncology Market Revenues & Volume, By Diagnostic Type, 2021 - 2031F |
6.1.3 Denmark Companion Diagnostics for Oncology Market Revenues & Volume, By Molecular Diagnostics, 2021 - 2031F |
6.1.4 Denmark Companion Diagnostics for Oncology Market Revenues & Volume, By Immunodiagnostics, 2021 - 2031F |
6.1.5 Denmark Companion Diagnostics for Oncology Market Revenues & Volume, By Genetic Testing, 2021 - 2031F |
6.1.6 Denmark Companion Diagnostics for Oncology Market Revenues & Volume, By Imaging-Based Diagnostics, 2021 - 2031F |
6.2 Denmark Companion Diagnostics for Oncology Market, By Cancer Type |
6.2.1 Overview and Analysis |
6.2.2 Denmark Companion Diagnostics for Oncology Market Revenues & Volume, By Lung Cancer, 2021 - 2031F |
6.2.3 Denmark Companion Diagnostics for Oncology Market Revenues & Volume, By Breast Cancer, 2021 - 2031F |
6.2.4 Denmark Companion Diagnostics for Oncology Market Revenues & Volume, By Colorectal Cancer, 2021 - 2031F |
6.2.5 Denmark Companion Diagnostics for Oncology Market Revenues & Volume, By Prostate Cancer, 2021 - 2031F |
6.3 Denmark Companion Diagnostics for Oncology Market, By Sample Type |
6.3.1 Overview and Analysis |
6.3.2 Denmark Companion Diagnostics for Oncology Market Revenues & Volume, By Blood, 2021 - 2031F |
6.3.3 Denmark Companion Diagnostics for Oncology Market Revenues & Volume, By Tissue, 2021 - 2031F |
6.3.4 Denmark Companion Diagnostics for Oncology Market Revenues & Volume, By Saliva, 2021 - 2031F |
6.3.5 Denmark Companion Diagnostics for Oncology Market Revenues & Volume, By Urine, 2021 - 2031F |
6.4 Denmark Companion Diagnostics for Oncology Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Denmark Companion Diagnostics for Oncology Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Denmark Companion Diagnostics for Oncology Market Revenues & Volume, By Diagnostic Centers, 2021 - 2031F |
6.4.4 Denmark Companion Diagnostics for Oncology Market Revenues & Volume, By Research Labs, 2021 - 2031F |
6.4.5 Denmark Companion Diagnostics for Oncology Market Revenues & Volume, By Pharmaceuticals, 2021 - 2031F |
6.5 Denmark Companion Diagnostics for Oncology Market, By Technology |
6.5.1 Overview and Analysis |
6.5.2 Denmark Companion Diagnostics for Oncology Market Revenues & Volume, By PCR-Based, 2021 - 2031F |
6.5.3 Denmark Companion Diagnostics for Oncology Market Revenues & Volume, By ELISA, 2021 - 2031F |
6.5.4 Denmark Companion Diagnostics for Oncology Market Revenues & Volume, By Microfluidics, 2021 - 2031F |
6.5.5 Denmark Companion Diagnostics for Oncology Market Revenues & Volume, By AI-Based Analysis, 2021 - 2031F |
7 Denmark Companion Diagnostics for Oncology Market Import-Export Trade Statistics |
7.1 Denmark Companion Diagnostics for Oncology Market Export to Major Countries |
7.2 Denmark Companion Diagnostics for Oncology Market Imports from Major Countries |
8 Denmark Companion Diagnostics for Oncology Market Key Performance Indicators |
8.1 Adoption rate of companion diagnostics by healthcare providers in Denmark |
8.2 Number of collaborations between diagnostic companies and pharmaceutical companies for companion diagnostics |
8.3 Investment in research and development for innovative companion diagnostic technologies |
9 Denmark Companion Diagnostics for Oncology Market - Opportunity Assessment |
9.1 Denmark Companion Diagnostics for Oncology Market Opportunity Assessment, By Diagnostic Type, 2021 & 2031F |
9.2 Denmark Companion Diagnostics for Oncology Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.3 Denmark Companion Diagnostics for Oncology Market Opportunity Assessment, By Sample Type, 2021 & 2031F |
9.4 Denmark Companion Diagnostics for Oncology Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Denmark Companion Diagnostics for Oncology Market Opportunity Assessment, By Technology, 2021 & 2031F |
10 Denmark Companion Diagnostics for Oncology Market - Competitive Landscape |
10.1 Denmark Companion Diagnostics for Oncology Market Revenue Share, By Companies, 2024 |
10.2 Denmark Companion Diagnostics for Oncology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here